OPC Pharmaceutical JSC (HOSE:OPC)
Vietnam
· Delayed Price · Currency is VND 22,500
+400 (1.81%)
At close: Mar 5, 2026
OPC Pharmaceutical JSC Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,122,987 | 968,576 | 1,004,887 | 1,171,614 | 1,123,728 | Upgrade
|
| Revenue Growth (YoY) | 15.94% | -3.61% | -14.23% | 4.26% | 16.38% | Upgrade
|
| Cost of Revenue | 591,453 | 522,458 | 526,456 | 637,906 | 643,499 | Upgrade
|
| Gross Profit | 531,534 | 446,118 | 478,431 | 533,708 | 480,229 | Upgrade
|
| Selling, General & Admin | 399,215 | 311,684 | 332,311 | 355,073 | 313,516 | Upgrade
|
| Operating Expenses | 399,215 | 311,684 | 332,311 | 355,073 | 313,516 | Upgrade
|
| Operating Income | 132,319 | 134,434 | 146,120 | 178,636 | 166,713 | Upgrade
|
| Interest Expense | - | - | -334.55 | -925.2 | -4,819 | Upgrade
|
| Interest & Investment Income | 19,075 | 8,335 | 15,854 | 7,813 | 3,707 | Upgrade
|
| Earnings From Equity Investments | 1,933 | 1,535 | 838.45 | 797.74 | 172.88 | Upgrade
|
| Currency Exchange Gain (Loss) | 861.55 | 448.73 | 555.41 | 279.37 | 360.84 | Upgrade
|
| Other Non Operating Income (Expenses) | -6,114 | -7,627 | -7,710 | -6,677 | -6,894 | Upgrade
|
| EBT Excluding Unusual Items | 148,074 | 137,126 | 155,323 | 179,924 | 159,241 | Upgrade
|
| Pretax Income | 148,074 | 137,126 | 155,323 | 179,924 | 159,241 | Upgrade
|
| Income Tax Expense | 31,623 | 27,672 | 33,004 | 37,530 | 35,878 | Upgrade
|
| Earnings From Continuing Operations | 116,451 | 109,454 | 122,319 | 142,394 | 123,363 | Upgrade
|
| Minority Interest in Earnings | -539.6 | -2,394 | -84.74 | -266.22 | 3,014 | Upgrade
|
| Net Income | 115,912 | 107,060 | 122,234 | 142,128 | 126,377 | Upgrade
|
| Preferred Dividends & Other Adjustments | 17,387 | 16,059 | 18,677 | 14,010 | 13,416 | Upgrade
|
| Net Income to Common | 98,525 | 91,001 | 103,557 | 128,118 | 112,961 | Upgrade
|
| Net Income Growth | 8.27% | -12.41% | -14.00% | 12.46% | 19.46% | Upgrade
|
| Shares Outstanding (Basic) | 64 | 64 | 64 | 64 | 64 | Upgrade
|
| Shares Outstanding (Diluted) | 64 | 64 | 64 | 64 | 64 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | -0.00% | Upgrade
|
| EPS (Basic) | 1538.23 | 1420.76 | 1616.80 | 2000.25 | 1763.61 | Upgrade
|
| EPS (Diluted) | 1538.00 | 1420.76 | 1616.80 | 2000.00 | 1763.61 | Upgrade
|
| EPS Growth | 8.25% | -12.13% | -19.16% | 13.40% | 19.16% | Upgrade
|
| Free Cash Flow | 43,753 | 12,147 | 243,317 | 28,688 | 181,809 | Upgrade
|
| Free Cash Flow Per Share | 683.10 | 189.65 | 3798.80 | 447.90 | 2838.51 | Upgrade
|
| Dividend Per Share | - | - | 1500.000 | 1500.000 | - | Upgrade
|
| Gross Margin | 47.33% | 46.06% | 47.61% | 45.55% | 42.73% | Upgrade
|
| Operating Margin | 11.78% | 13.88% | 14.54% | 15.25% | 14.84% | Upgrade
|
| Profit Margin | 8.77% | 9.40% | 10.30% | 10.94% | 10.05% | Upgrade
|
| Free Cash Flow Margin | 3.90% | 1.25% | 24.21% | 2.45% | 16.18% | Upgrade
|
| EBITDA | 153,874 | 156,652 | 169,015 | 201,454 | 189,215 | Upgrade
|
| EBITDA Margin | 13.70% | 16.17% | 16.82% | 17.20% | 16.84% | Upgrade
|
| D&A For EBITDA | 21,555 | 22,218 | 22,895 | 22,819 | 22,502 | Upgrade
|
| EBIT | 132,319 | 134,434 | 146,120 | 178,636 | 166,713 | Upgrade
|
| EBIT Margin | 11.78% | 13.88% | 14.54% | 15.25% | 14.84% | Upgrade
|
| Effective Tax Rate | 21.36% | 20.18% | 21.25% | 20.86% | 22.53% | Upgrade
|
| Revenue as Reported | 1,122,987 | 968,576 | 1,004,887 | 1,171,614 | 1,123,728 | Upgrade
|
| Advertising Expenses | 66,590 | 43,302 | 51,343 | 48,858 | 40,148 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.